Guizhou Chitianhua Co.,Ltd.

Equities

600227

CNE0000011Q5

Agricultural Chemicals

End-of-day quote Shanghai S.E. 06:00:00 2024-04-28 pm EDT 5-day change 1st Jan Change
1.8 CNY +4.05% Intraday chart for Guizhou Chitianhua Co.,Ltd. +11.11% -31.56%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Guizhou Chitianhua Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Guizhou Chitianhua Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tranche Update on Guizhou Chitianhua Co.,Ltd.'s Equity Buyback Plan announced on February 19, 2024. CI
Guizhou Chitianhua Co.,Ltd. announces an Equity Buyback for CNY 30 million worth of its shares. CI
Guizhou Chitianhua Co.,Ltd. authorizes a Buyback Plan. CI
Guizhou Chitianhua Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Guizhou Salvage Pharma Suspends Methanol Production MT
Guizhou Chitianhua Co.,Ltd.(XSSC:600227) added to S&P Global BMI Index CI
Guizhou Salvage Pharma to Absorb Daqin Hospital From Subsidiary MT
Guizhou Chitianhua Co.,Ltd. agreed to acquire Mining rights and related ancillary assets of Huaqiu Second Mine from Guizhou Chitianhua Huaqiu Mining for approximately CNY 900 million. CI
Guizhou Chitianhua Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Guizhou Chitianhua Unit's Drug Passes Regulatory Evaluation MT
Guizhou Salvage Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Guizhou Salvage Pharma to Take Full Control of Cancer Hospital For 15 Million Yuan MT
Guizhou Salvage Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Guizhou Salvage Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Guizhou Salvage Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Guizhou Salvage Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Guizhou Salvage Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Guizhou Salvage Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Guizhou Salvage Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Guizhou Salvage Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Guizhou Salvage Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020 CI
Guizhou Salvage Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020 CI
Guizhou Salvage Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019 CI
Chart Guizhou Chitianhua Co.,Ltd.
More charts
Guizhou Chitianhua Co Ltd, formerly Guizhou Salvage Pharmaceutical Co Ltd, is a China-based company mainly engaged in chemical production and pharmaceutical production. The chemical business mainly includes the production and sales of urea, methanol and compound fertilizer. The pharmaceutical manufacturing business mainly includes the production and sales of pharmaceuticals and medical devices. The Company's pharmaceutical products include diabetes drugs, cardiovascular drugs, dermatology drugs, gynecological drugs, digestive system drugs, endocrine drugs, psychotropic drugs, among others. The Company mainly conducts businesses within the domestic market.
More about the company
  1. Stock Market
  2. Equities
  3. 600227 Stock
  4. News Guizhou Chitianhua Co.,Ltd.
  5. Guizhou Salvage Pharma to Take Full Control of Cancer Hospital For 15 Million Yuan